RA
Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$22.55
-16.95%
Mkt Cap $1.24B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 May 7, 2026 | $7.50M | $20.00M | +166.67% | -$0.62 | -$0.42 | +32.70% |
| Q1 2026 Mar 10, 2026 | — | — | — | -$0.65 | -$0.72 | -10.77% |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.77 | -$0.71 | +7.79% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.87 | -$0.75 | +13.79% |
| Q2 2025 May 8, 2025 | — | — | — | -$0.77 | -$0.68 | +11.69% |
| Q1 2025 Mar 11, 2025 | — | — | — | -$0.62 | -$0.57 | +8.06% |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.57 | -$0.50 | +12.28% |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.68 | -$1.70 | -150.00% |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.12 | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.07 | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.05 | — |
| Q2 2023 Jun 29, 2023 | — | — | — | — | -$0.03 | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.03 | — |